Through the elucidation of various molecular, metabolic, and inflammatory pathways, we have provided insights into how adipose tissue-derived factors, altered insulin signaling, chronic inflammation, and dysregulated lipid metabolism collectively contribute to the increased risk of HCC among individuals with obesity. The gene discussed is INS; the disease is obesity disorder.